Handelsbanken Fonder’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
103,409
-9,700
| -9% | -$109K | ﹤0.01% | 892 |
|
|
2025
Q1 | $1.14M | Hold |
113,109
| – | – | ﹤0.01% | 884 |
|
|
2024
Q4 | $1.34M | Sell |
113,109
-78,300
| -41% | -$926K | 0.01% | 837 |
|
|
2024
Q3 | $2.21M | Buy |
191,409
+77,300
| +68% | +$892K | 0.01% | 632 |
|
|
2024
Q2 | $1.21M | Sell |
114,109
-9,900
| -8% | -$105K | 0.01% | 751 |
|
|
2024
Q1 | $1.31M | Buy |
124,009
+20,100
| +19% | +$212K | 0.01% | 738 |
|
|
2023
Q4 | $1.17M | Buy |
103,909
+22,000
| +27% | +$247K | 0.01% | 740 |
|
|
2023
Q3 | $957K | Buy |
81,909
+14,909
| +22% | +$174K | 0.01% | 744 |
|
|
2023
Q2 | $675K | Buy |
67,000
+53,500
| +396% | +$539K | ﹤0.01% | 911 |
|
|
2023
Q1 | $100K | Hold |
13,500
| – | – | ﹤0.01% | 1526 |
|
|
2022
Q4 | $108K | Buy |
+13,500
| New | +$108K | ﹤0.01% | 1509 |
|